Evidence map›Paper›PMID 30258765›Full record

ArticleMedical mycology case reports2018

Utilization of voriconazole drug monitoring in the treatment of cutaneous

McKenna E Boyd, Harry Dao, Jerry D Estep, Yve T Huttenbach, Vagish Hemmige

Open access · goldAbstract readCase Reports
In one paragraph

Article in Medical mycology case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. [Uveitis complicated by Scedosporium apiospermum sensu stricto: relevance of early diagnosis and its multidisciplinary management].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2023
    Article
  3. A case of cutaneousSkin health and disease · 2023
    Article
  4. A Case of Invasive Fungal Infection Due toInfection and drug resistance · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

McKenna E BoydBaylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, United States.
Harry DaoDepartment of Dermatology, Baylor College of Medicine, 1977 Butler Blvd, Houston, TX 77030, United States.
Jerry D EstepDepartment of Cardiology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, United States.
Yve T HuttenbachDepartment of Pathology, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, United States.
Vagish HemmigeDepartment of Infectious Disease, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, United States.
Baylor College of Medicine · USCleveland Clinic · USMontefiore Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the use of voriconazole troughs to achieve appropriate therapeutic levels in treatment of a cutaneous Scedosporium apiospermum infection. Following heart transplantation, a 63-year-old immunocompromised patient presented with post-traumatic nodular lesions on his right shin. Pathology showed fungal yeasts with culture revealing Scedosporium apiospermum. According to therapeutic drug monitoring, initial voriconazole treatment was subtherapeutic requiring increased dosing until appropriate therapeutic trough levels were attained, and resolution of the fungal infection was achieved.

Indexed as

Cutaneous Scedosporium apiospermumImmunocompromisedTransplantTroughVoriconazole

Identifiers

PMID30258765
PMCPMC6154461
OpenAlexW2891264606

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.